1 |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality world wide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2 |
吴国明,钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408.
|
3 |
Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(5): 497-530.
|
4 |
Ghosn M, Solomon SB. Current management of oligometastatic lung cancer and future perspectives: results of thermal ablation as a local ablative therapy[J]. Cancers (Basel), 2021, 13(20): 5202.
|
5 |
Páez-Carpio A, Gómez FM, Isus Olivé G, et al. Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art[J]. Insights Imaging, 2021, 12(1): 57.
|
6 |
Mansur A, Garg T, Shrigiriwar A, et al. Image-guided percutaneous ablation for primary and metastatic tumors[J]. Diagnostics (Basel), 2022, 12(6): 1300.
|
7 |
Sonntag PD, Hinshaw JL, Lubner MG, et al. Thermal ablation of lung tumors[J]. Surg Oncol Clin N Am, 2010, 20(2): 369-387.
|
8 |
Palussière J, Catena V, Buy X. Percutaneous thermal ablation of lung tumors-Radiofrequency, microwave and cryotherapy: Where are we going?[J]. Diagn Interv Imaging, 2017, 98(9): 619-625.
|
9 |
Gala K, Shetty N, Patel P, et al. Microwave ablation: How we do it?[J]. Indian J Radiol Imaging, 2020, 30(2): 206-213.
|
10 |
Lin M, Eiken P, Blackmon S. Image guided thermal ablation in lung cancer treatment[J]. J Thorac Dis, 2020, 12(11): 7039-7047.
|
11 |
Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)[J]. Lancet Oncol, 2008, 9(7): 621-628.
|
12 |
Ni Y, Huang GH, Yang X, et al. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results[J]. Eur Radiol, 2022, 32(8): 5616-5622.
|
13 |
Palussière J, Chomy F, Savina M, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase Ⅱ trial [J]. J Cardiothorac Surg, 2018, 13(1): 91.
|
14 |
Huang BY, Li XM, Song XY, et al. Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study[J]. Int J Surg, 2018, 53(undefined): 143-150.
|
15 |
Iezzi R, Cioni R, Basile D, et al. Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study)[J]. Eur Radiol, 2021, 31(4): 2173-2182.
|
16 |
Michael L, Amita S, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2009, 137(1): 160-166.
|
17 |
Zhao H, Steinke K. Long-term outcome following microwave ablation of early- stage non-small cell lung cancer [J]. J Med Imaging Radiat Oncol, 2020, 64(6): 787-793.
|
18 |
Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the american college of surgeons oncology group Z4033 (Alliance) trial[J]. Cancer, 2015, 121(19): 3491-3498.
|
19 |
Nance M, Khazi Z, Kaifi J, et al. Computerized tomography-guided microwave ablation of patients with stage I non-small cell lung cancers: A single- institution retrospective study[J]. J Clin Imaging Sci, 2021, 11: 7.
|
20 |
Ambrogi MC, Fanucchi O, Cioni R, et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study[J]. J Thorac Oncol, 2011, 6(12): 2044-2051.
|
21 |
Wang Y, Liu B, Cao P, et al. Comparison between computed tomography-guided percutaneous microwave ablation and thoracoscopic lobectomy for stage I non-small cell lung cancer[J]. Thorac Cancer, 2018, 9(11): 1376-1382.
|
22 |
Xia Y, Xin YE, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases [J]. J Surg Oncol, 2014, 110(6): 758-763.
|
23 |
Narsule CK, Sridhar P, Nair D, et al. Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up[J]. J Thorac Dis, 2017, 9(10): 4039-4045.
|
24 |
Ito N, Nakatsuka S, Inoue M, et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation[J]. J Vase Interv Radiol, 2012, 23(8): 1043-1052.
|
25 |
Nomori H, Yamazaki I, Shiraishi A, et al. Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen[J]. Eur J Radiol, 2020, 133: 109334.
|
26 |
Liu SP, Zhu XH, Qin ZL, et al. Computed tomography-guided percutaneous cryoablation for lung ground-glass opacity: A pilot study[J]. J Cancer Res Ther, 2019, 15(2): 370-374.
|
27 |
Ye X, Fan W, Wang Z, et al. Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition) [J]. J Cancer Res Ther, 2021, 17(5): 1141-1156.
|
28 |
Mikami S, Tateishi R, Akahane M, et al. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience[J]. J Vasc Interv Radiol, 2012, 23(10): 1269-1275.
|
29 |
Minami Y, Kudo M. Imaging modalities for assessment of treatment response to nonsurgical hepatocellular carcinoma therapy: Contrast-Enhanced US, CT, and MRI[J]. Liver Cancer, 2015, 4(2): 106-114.
|
30 |
Roman A, Kaltenbach B, Gruber-Rouh T, et al. The role of MRI in the early evaluation of lung microwave ablation[J]. Int J Hyperthermia, 2018, 34(6): 883-890.
|
31 |
Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation[J]. Radiology, 2010, 254(1): 301-307.
|
32 |
Bi N, Shedden K, Zheng X, et al. Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review and pooled analysis[J]. Int J Radiat Oncol Biol Phys, 2016, 95(5): 1378-1390.
|
33 |
Zhang R, Kang J, Ren S, et al. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis[J]. Ann Transl Med, 2022, 10(2): 104.
|
34 |
Uhlig J, Ludwig JM, Goldberg SB, et al. Survival rates after thermal ablation versus stereotactic radiation therapy for stage I non-small cell lung cancer: a national cancer database study[J]. Radiology, 2018, 289(3): 862-870.
|
35 |
Mendogni P, Daffre E, Rosso L, et al. Percutaneous lung microwave ablation versus lung resection in high-risk patients. A monocentric experience[J]. Acta Biomed, 2020, 91(10S): e2020002.
|
36 |
Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study[J]. J Thorac Cardiovasc Surg, 2020, 160(5): 1350-1357.
|
37 |
Zeng C, Lu J, Tian Y, et al. Thermal ablation versus wedge resection for stage I non-small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database[J]. Front Oncol, 2020, 10: 571684.
|
38 |
Zhao H, Fan K, Wang HY, et al. Treatment of stage Ia non-small cell lung cancer in patients: comparison of ablation and sub-lobectomy[J]. Zhongguo Fei Ai Za Zhi, 2021, 24(9): 613-622.
|
39 |
Callstrom MR, Woodrum DA, Nichols FC, et al. Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE)[J]. J Thorac Oncol, 2020, 15(7): 1200-1209.
|
40 |
Wang Q, Huang J, Ma K, et al. Evaluation of ghost cell survival in the area of radiofrequency ablation[J]. PLoS One, 2012, 7(12): e53158.
|
41 |
Tselikas L, de Baere T, Deschamps F, et al. Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation[J]. Eur Radiol, 2017, 27(3): 1211-1217.
|
42 |
Wang J, Ni Y, Yang X, et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity[J]. J Cancer Res Ther, 2019, 15(4): 755-759.
|
43 |
Alzubaidi SJ, Liou H, Saini G, et al. Percutaneous image-guided ablation of lung tumors[J]. J Clin Med, 2021, 10(24): 5783.
|
44 |
Aufranc V, Farouil G, Abdel-Rehim M, et al. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation[J]. Diagn Interv Imaging, 2019, 100(12): 781-791.
|
45 |
Tafti BA, Genshaft S, Suh R, et al. Lung ablation: indications and techniques[J]. Semin Intervent Radiol, 2019, 36(3): 163-175.
|
46 |
Abtin F, De Baere T, Dupuy DE, et al. Updates on current role and practice of lung ablation[J]. J Thorac Imaging, 2019, 34(4): 266-277.
|
47 |
Vyas V, Paul M. Catastrophic complications following cryoablation of lung cancer[J]. Proc (Bayl Univ Med Cent), 2020, 34(1): 131-132.
|
48 |
Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques[J]. Semin Intervent Radiol, 2013, 30(2): 141-150.
|
49 |
Palussière J, Cazayus M, Cousin S, et al. Is there a role for percutaneous ablation for early stage lung cancer? What is the evidence?[J]. Curr Oncol Rep, 2021, 23(7): 81.
|
50 |
Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours[J]. Cardiovasc Intervent Radiol, 2020, 43(5): 667-683.
|
51 |
Genshaft SJ, Suh RD, Abtin F, et al. Society of interventional radiology multidisciplinary position statement on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs: endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology[J]. J Vasc Interv Radiol, 2021, 32(8): 1241.e1-e12.
|
52 |
Wang M, Wei Z, Ye X. Issues and prospects of image-guided thermal ablation in the treatment of primary and metastatic lung tumors[J]. Thorac Cancer, 2023, 14(1): 110-115.
|